Lung Cancer Surgery Market was worth USD 21.58 billion in 2016 and is expected to reach USD 30.32 billion by 2021 with a CAGR of 6.92%.
Lung Cancer is a type of Cancer that starts in Trachea, Bronchus or lung Tissue. They are many ways to treat Lung Cancer.
Some of them are Chemotherapy, Radiotherapy, Laser therapy, and Surgery. Surgery involves removal of infected section from lungs.
Full report at: www.marketdataforecast.com/market-…gery-market-1983/
Lung Cancer is kind of cancer which starts in Lung tissue or its surrounding parts. There are various types of treatments available to treat cancer like Chemotherapy, Radiotherapy, Laser Therapy and Surgery.
Surgery involves removal of infected part from the lungs.
In some cases, surgery will be used with other treatment methods to cure cancer. Surgery is only used if cancer cells don’t spread very near to the heart.
Rising pollution levels, increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer and rising geriatric population are some of the major factors driving the market. However, high cost of Lung Cancer surgery is restraining the growth of the market.
Lung Cancer Surgery Market is segmented based on Procedure and Device. Based on Procedure, market is segmented into Thoracotomy and Minimally Invasive.
Based on Thoracotomy, market is further segmented into Lobectomy, Pneumonectomy, Sleeve Resection, and Segmentectomy. Based on Device, market is segmented into Surgical, Monitoring and Visualizing Systems.
Based on Surgical Devices, market is further segmented into Clamps, Forceps, Retractors, Staplers, Cutters, Scissors, Elevators, RIB Sheers, Trocars. Based on Monitoring Devices, market is further segmented into Cameras & Video Support.
Based on Visualizing Devices, market is further segmented into Endoscopic Trocars with optical views, Endo surgical Equipment. Surgical Instruments segment is expected to dominate the market owing to the shorter lifespan of devices and wider adoption of these devices.
Minimally Invasive surgeries are expected to grow at highest CAGR owing to the rising awareness among people for early detection of lung cancer and advantages of Minimally Invasive Surgeries over conventional surgeries.
Geographically, market is further segmented into Asia-Pacific, Europe, Latin America, North America and Middle East and Africa. North America accounted for largest share in the market owing to rising geriatric population, increasing reimbursements for surgeries, and technological advancement in this field.
Request sample: www.marketdataforecast.com/market-…83/request-sample
Key players in the market include Ethicon US LLC, Intuitive Surgical Inc., Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Inc., KARL STORZ GmbH, Ackermann Instrumente GmbH, Scanlan International Inc., and Trokamed GmbH.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!